BioMedPartners
Investor profile
Venture capital
BioMedPartners has backed 11 European tech companies across 15 funding rounds between 2011 and 2024, joining rounds totalling €430M. Most active in Healthtech. Data as of Nov 2026.
Also recorded as: BioMed Partners
Deals
15
distinct rounds
Companies
11
backed
Active span
2011–2024
14 yrs
Total round €
€430M
sum of rounds joined
Deals by year
distinct rounds / yearBioMedPartners — deals by year — interactive chart.
Data table
| BioMedPartners — deals by year | |
|---|---|
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 4 |
| 2024 | 1 |
Top sectors
by dealsBioMedPartners — top sectors — interactive chart.
Data table
| BioMedPartners — top sectors | |
|---|---|
| Healthtech | 15 |
Stages
by dealsBioMedPartners — stages — interactive chart.
Data table
| BioMedPartners — stages | |
|---|---|
| Series B | 7 |
| Series A | 5 |
| Series C | 2 |
| Series D+ | 1 |
Countries
by dealsBioMedPartners — countries — interactive chart.
Data table
| BioMedPartners — countries | |
|---|---|
| Switzerland | 7 |
| Germany | 5 |
| Austria | 1 |
| Belgium | 1 |
| Netherlands | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- GIMV4
- High-Tech Gründerfonds (HTGF)3
- INKEF Capital3
- Pfizer Ventures3
- Coparion2
- Evotec2
- FundPlus2
- Mission BioCapital2
- Sunstone Capital2
- Vesalius Biocapital Partners2
- VI Partners2
- Andera Partners1
- Bayern Kapital1
- BioGeneration Ventures1
- Boehringer Ingelheim Venture Fund1
- Bristol Myers Squibb1
- Double Point Ventures1
- Earlybird Venture Capital1
- EIR Ventures1
- EMBL Ventures1
- EntrePREneurs Fund1
- Epidarex Capital1
- Fiscus Financial1
- Forbion1
- GL Capital1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Immunos Therapeutics | Switzerland | 3 | €92M |
| Precirix | Belgium | 1 | €80M |
| Tubulis Technologies | Germany | 2 | €71M |
| Cardior Pharmaceuticals | Germany | 1 | €64M |
| Topas Therapeutics | Germany | 2 | €40M |
| Scenic Biotech | Netherlands | 1 | €28M |
| GenKyoTex | Switzerland | 1 | €17M |
| Anergis | Switzerland | 1 | €14M |
| Alentis Therapeutics | Switzerland | 1 | €11M |
| Sequana Medical | Switzerland | 1 | €8.3M |
| Miracor Medical Systems | Austria | 1 | €4.5M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Precirix | Series B | €80M | 2022-03 |
| Immunos Therapeutics | Series B | €68M | 2022-06 |
| Cardior Pharmaceuticals | Series B | €64M | 2021-08 |
| Tubulis Technologies | Series B | €60M | 2022-05 |
| Scenic Biotech | Series A | €28M | 2022-03 |
| Topas Therapeutics | Series B | €22M | 2020-10 |
| Topas Therapeutics | Series B | €18M | 2021-07 |
| GenKyoTex | Series D+ | €17M | 2015-01 |
| Anergis | Series A | €14M | 2011-03 |
| Immunos Therapeutics | Series A | €14M | 2019-10 |